|
|
||||||||
Ann Thorac Surg 2006;81:815-819
© 2006 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery, Joseph B. Whitehead Department of Surgery, Emory University and Emory Crawford Long Hospitals, Emory University School of Medicine, Atlanta, Georgia
Accepted for publication August 29, 2005.
* Address correspondence to Dr Guyton, Division of Cardiothoracic Surgery, Medical Office Tower, 6th Floor, Emory Crawford Long Hospital, 550 Peachtree St, NE, Atlanta, GA 30308 (Email: rguyton{at}emoryhealthcare.org).
BACKGROUND: Patients who undergo off-pump coronary artery bypass graft surgery (OPCAB) may be hypercoagulable with an increased risk of graft thrombosis due to the lack of platelet dysfunction that accompanies "on-pump" surgery. Clopidogrel may be indicated in these patients to prevent recurrent ischemic events. The purpose of this observational study was to determine the safety of early clopidogrel administration after OPCAB.
METHODS: Thirty-day follow-up of 364 consecutive OPCAB patients (January to June, 2002) was determined from a computerized database. One hundred ninety-three patients received clopidogrel 4 hours postoperatively if chest tube output was less than 100 cc/h for 4 hours, then daily for 4 weeks. Aspirin was administered preoperatively and postoperatively to all patients. Telephone follow-up was made 6 to 12 months after OPCAB.
RESULTS: None of the patients who received clopidogrel in the early postoperative period required reoperation for mediastinal hemorrhage. Mean chest tube drainage at 24 hours was 1,024 ± 563 mL in patients who received clopidogrel and 942 ± 501 mL in patients who did not receive clopidogrel. The total number of blood units transfused and the number of patients receiving blood transfusions were similar between groups. In-hospital mortality was 1.6% in patients who received clopidogrel and 3.5% in patients who did not receive clopidogrel. No group differences in mortality or adverse cardiac events were observed at 6 months. Gastrointestinal bleeding occurred in 2.2% clopidogrel patients versus 0.7% of patients who did not receive clopidogrel.
CONCLUSIONS: When administered according to our postoperative protocol, OPCAB patients can safely receive clopidogrel in the early postoperative period without increased risk for mediastinal hemorrhage.
This article has been cited by other articles:
![]() |
J. Sullivan and N. Amarshi Dual antiplatelet therapy with clopidogrel and aspirin Am. J. Health Syst. Pharm., June 15, 2008; 65(12): 1134 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Englberger, M. Streich, H. Tevaearai, and T. P. Carrel Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 378 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukui, S. Takanashi, Y. Hosoda, and S. Suehiro Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting Ann. Thorac. Surg., January 1, 2007; 83(1): 115 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dalainas, G. Nano, M. Randall, F. McKevitt, G. Venables, T. Cleveland, and P. Gaines Compatibility of Carotid Stenting and Cardiac Surgery Stroke, May 1, 2006; 37(5): 1153 - 1154. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |